RGEN: Repligen Corporation Stock

by  •  • Comments Off on RGEN: Repligen Corporation Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 8,770.98
Enterprise Value ($M) 8,578.11
Book Value ($M) 1,986.36
Book Value / Share 35.45
Price / Book 4.42
NCAV ($M) 317.61
NCAV / Share 5.67
Price / NCAV 27.62

Profitability (mra)
Return on Invested Capital (ROIC) -0.00
Return on Assets (ROA) -0.00
Return on Equity (ROE) -0.00

Liquidity (mrq)
Quick Ratio 8.76
Current Ratio 10.44

Balance Sheet (mrq) ($M)
Current Assets 1,131.57
Assets 2,830.64
Liabilities 813.96
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G/A Price T Rowe Associates Inc /md/ 11.40 4.47
11-12 13G/A BlackRock, Inc. 12.70 0.00
02-13 13G/A Vanguard Group Inc 9.10 -2.44
02-06 13G/A Eddleman Roy T 4.85 0.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-22 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-15 110,585 403,678 27.39
2025-01-14 168,043 520,438 32.29
2025-01-13 124,060 424,337 29.24
2025-01-10 82,863 497,914 16.64

(click for more detail)

Similar Companies
RDUS – Radius Recycling, Inc. REGN – Regeneron Pharmaceuticals, Inc.
REPL – Replimune Group, Inc. RGNX – REGENXBIO Inc.
RIGL – Rigel Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io